WuXi Biologics and Virogen Bio partner to advance VG712
WuXi Biologics, which happens to be a leading global contract research, development, and manufacturing organization (CRDMO), on June 9, 2025, happened to announce a...
Construction of WuXi Biologics Microbial Manufacturing Site
WuXi Biologics, which happens to be a leading global contract research, development, and manufacturing organization (CRDMO), on June 9, 2025, went on to announce...
Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season
In a recent development, Sanofi is shipping Beyfortus – nirsevimab starting early Q3 of 2025 in order to ensure a very broad availability. Well...
Thermo Fischer Accelerator Drug Development an Ideal Choice
Thermo Fisher Scientific Inc., which happens to be the world leader in serving science, on the 16th of June, 2025 announced the findings of...
IQVIA Custom-Built AI Agents for Life Sciences, Healthcare
IQVIA, which happens to be a leading global provider of clinical research services, healthcare intelligence to the life sciences and healthcare industries, and also...
SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges
SCHOTT Pharma begins construction on a new production facility for ready-to-use cartridges in Hungary.
The company's investment of more than EUR 100 million...
Stringent Policy around COVID Vaccines Laid by FDA
The US FDA is now tightening its regulatory policy around COVID vaccines by setting up a new framework that raises the bar for certain...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...